Jiangsu Nhwa Pharmaceutical Co.,Ltd.
恩华药业
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Biotech/Healthcare
Enhua Pharmaceutical focuses on the central nervous system drug market. Its core business is the development, manufacturing, and sale of CNS drugs.
Latest round: Post-IPO (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.